NCT03365765View on ClinicalTrials.gov

mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

December 22, 2022

Study Completion Date

December 31, 2022

Conditions

Apatinib

Interventions

DRUG

Apatinib

Apatinib tablet

DRUG

Oxaliplatin

Oxaliplatin Intravenous

DRUG

5-fluorouracil

5-fluorouracil Intravenous

Trial Locations (1)

200040

Huashan Hospital Affiliated to Fudan University, Shanghai

All Listed Sponsors

lead

Huashan Hospital

OTHER

NCT03365765 - mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer | Biotech Hunter | Biotech Hunter